LIGAND PHARMACEUTICALS INC

Insider Reports History

Location
San Diego, CA
Signature
/s/ Octavio Espinoza, Chief Financial Officer of Ligand Pharmaceuticals Incorporated
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by LIGAND PHARMACEUTICALS INC:

Company Role Class Num Shares Value Price $ Report Date Ownership
Channel Therapeutics Corp Director, 10%+ Owner Common Stock 1,500,000 $15,000,000 $10.00 01 Jul 2025 Direct
Channel Therapeutics Corp Director, 10%+ Owner Series A Convertible Preferred Stock 34,279 01 Jul 2025 Direct
OmniAb Operations, Inc. 10%+ Owner Common Stock 0 01 Nov 2022 Direct
Pelthos Therapeutics Inc. Director, 10%+ Owner Senior Secured Convertible Note $9,000,000 17 Dec 2025 Direct

Insider Reports Filed by LIGAND PHARMACEUTICALS INC

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CHRO Pelthos Therapeutics Inc. 17 Dec 2025 2 $0 4 Director, 10%+ Owner 19 Dec 2025, 16:15
CHRO Pelthos Therapeutics Inc. 06 Nov 2025 1 +$9,000,000 4 Director, 10%+ Owner 10 Nov 2025, 16:43
CHRO Pelthos Therapeutics Inc. 01 Jul 2025 3 +$15,000,000 4 10%+ Owner 03 Jul 2025, 09:33
CHRO Pelthos Therapeutics Inc. 01 Jul 2025 0 $0 3 10%+ Owner 03 Jul 2025, 09:28
/report/000089924322035055-ligand-pharmaceuticals-inc-2022-11-01 OmniAb Operations, Inc. 01 Nov 2022 1 $0 4 10%+ Owner 03 Nov 2022, 21:12
/report/000089924322032347-ligand-pharmaceuticals-inc-2022-09-30 OmniAb, Inc. 30 Sep 2022 0 $0 3 10%+ Owner 30 Sep 2022, 19:59